CTOR
Citius Oncology
CTOR
CTOR
22 hedge funds and large institutions have $56.8M invested in Citius Oncology in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2.93M
Holders
22
Holding in Top 10
–
Calls
–
Puts
$2.93M
Top Buyers
| 1 | +$3.67M | |
| 2 | +$2.11M | |
| 3 | +$1.42M | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$774K |
| 5 |
VF
Virtu Financial
New York
|
+$338K |
Top Sellers
| 1 | -$3.64M | |
| 2 | -$2.59M | |
| 3 | -$202K | |
| 4 |
SG
StoneX Group
New York
|
-$188K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$131K |